These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 9310127)
1. In vitro study of Seraspenide on HIV-induced inhibition of granulopoiesis. Coutton C; Chermann JC Eur J Haematol; 1997 Sep; 59(3):184-9. PubMed ID: 9310127 [TBL] [Abstract][Full Text] [Related]
2. HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth. Calenda V; Chermann JC Eur J Haematol; 1995 Mar; 54(3):180-5. PubMed ID: 7536687 [TBL] [Abstract][Full Text] [Related]
3. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654). Genevay MC; Mormont C; Thomas F; Berthier R Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796 [TBL] [Abstract][Full Text] [Related]
4. Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis. Koller MR; Manchel I; Palsson BO Stem Cells; 1997; 15(4):305-13. PubMed ID: 9253115 [TBL] [Abstract][Full Text] [Related]
5. Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5. King AG; Talmadge JE; Badger AM; Pelus LM Exp Hematol; 1992 Feb; 20(2):223-8. PubMed ID: 1544391 [TBL] [Abstract][Full Text] [Related]
6. Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication. Costantini A; Giuliodoro S; Mancini S; Butini L; Regnery CM; Silvestri G; Greco F; Leoni P; Montroni M AIDS; 2006 Aug; 20(13):1713-20. PubMed ID: 16931935 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors. Bonnet D; Lemoine FM; Najman A; Guigon M Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684 [TBL] [Abstract][Full Text] [Related]
9. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors. Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956 [TBL] [Abstract][Full Text] [Related]
10. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Ruggieri L; Heimfeld S; Broxmeyer HE Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350 [TBL] [Abstract][Full Text] [Related]
11. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1. Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587 [TBL] [Abstract][Full Text] [Related]
12. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394 [TBL] [Abstract][Full Text] [Related]
13. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106 [TBL] [Abstract][Full Text] [Related]
14. HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors. Zauli G; Capitani S Pathobiology; 1996; 64(1):53-8. PubMed ID: 8856796 [TBL] [Abstract][Full Text] [Related]
15. Inducing effects of macrophage stimulating protein on the expansion of early hematopoietic progenitor cells in liquid culture. Ma LX; Huang YH; Cheng LM; Lei J; Wang QR Chin Med J (Engl); 2007 Jul; 120(13):1192-7. PubMed ID: 17637252 [TBL] [Abstract][Full Text] [Related]
16. In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis. Aglietta M; Piacibello W; Stacchini A; Sanavio F; Gavosto F Leuk Res; 1985; 9(7):879-83. PubMed ID: 3860698 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo. Laerum OD; Paukovits WR Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268 [TBL] [Abstract][Full Text] [Related]
19. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. Reid CD; Stackpoole A; Meager A; Tikerpae J J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells. Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]